Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis

The soluble urokinase-type plasminogen activator receptor (suPAR) has evolved as a useful biomarker for different entities of chronic liver disease. However, its role in patients with primary sclerosing cholangitis (PSC) is obscure. We analyzed plasma levels of suPAR in 84 patients with PSC and comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Özdirik, Burcin, Maibier, Martin, Scherf, Maria, Nicklaus, Jule Marie, Frohme, Josephine, Puengel, Tobias, Meyer zum Büschenfelde, Dirk, Tacke, Frank, Mueller, Tobias, Sigal, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105770/
https://www.ncbi.nlm.nih.gov/pubmed/35566603
http://dx.doi.org/10.3390/jcm11092479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105770/
https://www.ncbi.nlm.nih.gov/pubmed/35566603
http://dx.doi.org/10.3390/jcm11092479

Ejemplares similares